Business description: Shire
- sales of products (95.3%);
- other (4.7%): primarily franchise royalties.
Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Company details: Shire
Group companies: Shire
| Name | Category and Sector |
|---|---|
Shire Licensing VOF | |
Shire Pharmaceuticals Ireland Ltd.
 Shire Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products |
Pharmaceuticals: Major
|
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.40% | -1.93% | +56.32% | +106.62% | 1,034B | |
| +0.87% | +4.16% | +55.51% | +72.28% | 663B | |
| -0.56% | +0.50% | +22.46% | +77.58% | 462B | |
| +2.56% | -1.98% | +32.39% | +38.48% | 344B | |
| +0.21% | +5.46% | +27.51% | +47.64% | 307B | |
| +1.43% | +0.12% | -0.67% | +13.45% | 251B | |
| +0.02% | +1.25% | +55.87% | +74.18% | 239B | |
| +0.23% | +2.02% | -17.40% | -54.04% | 207B | |
| +0.05% | +0.46% | +32.35% | +98.97% | 186B | |
| Average | +0.45% | -0.70% | +29.37% | +52.80% | 410.37B | |
| Weighted average by Cap. | +0.31% | -0.84% | +38.08% | +67.75% |
